Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Damond

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
AIDS (London, England)|December 31, 2008
Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patientsRoland Landman, Florence Damond, Juliette Gerbe, et al.
Journal of Medical Virology|June 18, 2015
Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infectionsAgnès Gautheret-Dejean, Jonathan Bocobza, Sylvie Brunet, et al.
Journal of Medical Virology|September 25, 2015
Response to Hønge et al.: Comment on Gautheret-Dejean et al.: Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infectionsAgnès Gautheret-Dejean, Jonathan Bocobza, Sylvie Brunet, et al.
Antiviral Therapy|February 22, 2007
Rare selection of the K65R mutation in antiretroviral-naive patients failing a first-line abacavir/ lamivudine-containing HAART regimenDiane Descamps, Mounir Ait-Khaled, Charles Craig, et al.
The Journal of Infectious Diseases|January 15, 2004
Interclade neutralization and enhancement of human immunodeficiency virus type 1 identified by an assay using HeLa cells expressing both CD4 receptor and CXCR4/CCR5 coreceptorsFrancis Barin, Sylvie Brunet, Denys Brand, et al.
AIDS (London, England)|March 28, 2003
Impact of antiretroviral treatment on the tropism of HIV-1 plasma virus populationsKatharina Skrabal, Virginie Trouplin, Béatrice Labrosse, et al.
Journal of Clinical Microbiology|December 8, 2004
Rapid discrimination between human immunodeficiency virus type 2 groups A and B by real-time PCRJean-Christophe Plantier, Marie Gueudin, Fabienne de Oliveira, et al.
Retrovirology|August 23, 2011
G140S/Q148R and N155H mutations render HIV-2 Integrase resistant to raltegravir whereas Y143C does notXiao-Ju Ni, Olivier Delelis, Charlotte Charpentier, et al.
AIDS (London, England)|December 6, 2005
Proliferative, IFNgamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infectionNadia Alatrakchi, Florence Damond, Sophie Matheron, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2002
Amprenavir inhibitory quotient and virological response in human immunodeficiency virus-infected patients on an amprenavir-containing salvage regimen without or with ritonavirXavier Duval, Claire Lamotte, Ester Race, et al.
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
AIDS (London, England)|December 31, 2008
Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patientsRoland Landman, Florence Damond, Juliette Gerbe, et al.
Journal of Medical Virology|June 18, 2015
Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infectionsAgnès Gautheret-Dejean, Jonathan Bocobza, Sylvie Brunet, et al.
Journal of Medical Virology|September 25, 2015
Response to Hønge et al.: Comment on Gautheret-Dejean et al.: Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infectionsAgnès Gautheret-Dejean, Jonathan Bocobza, Sylvie Brunet, et al.
Antiviral Therapy|February 22, 2007
Rare selection of the K65R mutation in antiretroviral-naive patients failing a first-line abacavir/ lamivudine-containing HAART regimenDiane Descamps, Mounir Ait-Khaled, Charles Craig, et al.
The Journal of Infectious Diseases|January 15, 2004
Interclade neutralization and enhancement of human immunodeficiency virus type 1 identified by an assay using HeLa cells expressing both CD4 receptor and CXCR4/CCR5 coreceptorsFrancis Barin, Sylvie Brunet, Denys Brand, et al.
AIDS (London, England)|March 28, 2003
Impact of antiretroviral treatment on the tropism of HIV-1 plasma virus populationsKatharina Skrabal, Virginie Trouplin, Béatrice Labrosse, et al.
Journal of Clinical Microbiology|December 8, 2004
Rapid discrimination between human immunodeficiency virus type 2 groups A and B by real-time PCRJean-Christophe Plantier, Marie Gueudin, Fabienne de Oliveira, et al.
Retrovirology|August 23, 2011
G140S/Q148R and N155H mutations render HIV-2 Integrase resistant to raltegravir whereas Y143C does notXiao-Ju Ni, Olivier Delelis, Charlotte Charpentier, et al.
AIDS (London, England)|December 6, 2005
Proliferative, IFNgamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infectionNadia Alatrakchi, Florence Damond, Sophie Matheron, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2002
Amprenavir inhibitory quotient and virological response in human immunodeficiency virus-infected patients on an amprenavir-containing salvage regimen without or with ritonavirXavier Duval, Claire Lamotte, Ester Race, et al.
Pageof 12